NUVOX PHARMA, L.L.C. is associated with UEI WHNYG96UDLJ8 and CAGE 51P42 in public federal records. AcornBids currently links 1 prime award totaling $356.4K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541713 (Research and Development in Nanotechnology). Its public SAM.gov registration lists TUCSON, AZ, USA.
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Aug 20, 2026. Refresh pending; these totals may be out of date.
Public SAM.gov registration details.
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75A50123C00034RESEARCH AND DEVELOPMENT - AOI #19 FOR THE DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 FOR COVID19: EXTEND | Department of Health and Human Services | $356.4K | Jul 28, 2023 | May 31, 2025 |
| Registration evidence | Date |
|---|---|
| SAM updated | Jan 9, 2026 |
| Source loaded | Sep 2, 2026 |
| Initial registration | Apr 5, 2008 |
| Entity start | Mar 20, 2008 |
Registration classifications: Self Certified Small Disadvantaged Business, Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541713 — Research and Development in Nanotechnology | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| RONG WANG | Government business | Contact method not published | SAM registration | Not available |
| JENNY JOHNSON | Electronic business | Contact method not published | SAM registration | Not available |
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Explore the customer, work and award-size evidence behind each match.
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
1635 E 18TH ST, TUCSON, Arizona 85719, United States
Registered location from SAM.gov; award performance locations may differ.
541713 — Research and Development in Nanotechnology.
Primary SAM.gov NAICS classification.
Department of Health and Human Services.
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit